#hm-treasury

[ follow ]
#astrazeneca #new-york-listing #stamp-duty-reserve-tax #aria #spending-review #uk-science-funding
Business
fromwww.theguardian.com
4 days ago

Time for Reeves to recognise reality: AstraZeneca has killed stamp duty on shares | Nils Pratley

AstraZeneca's New York primary listing widens US investor access while causing roughly £200m annual UK stamp-duty losses, exposing flaws in the current stamp duty regime.
fromTheregister
2 months ago

UK science agency ARIA spared Treasury savings squeeze

a minimum of 5 percent savings and efficiencies against their current budgets.
UK politics
[ Load more ]